Director of the Institute for Diabetes and Endocriology and W3 Professor, Chair for Metabolic Programming, Technical University of Munich (TUM)
Prof. Dr. Henriette Uhlenhaut
"Hormones control every second of every day of our lives! Here at IDE, we aim to harness the power of hormones to find novel therapeutic approaches for the treatment of metabolic and inflammatory disorders, and for healthier, longer lives."
Academic Career and Research Areas
Prof. Uhlenhaut's (*1977) research focuses on investigating gene regulatory mechanisms that mediate hormone responses. Latest genome-wide techniques are combined with preclinical models to find new therapeutic approaches for metabolic or inflammatory diseases (e.g. diabetes, asthma).
Prof. Uhlenhaut studied at the Technical University of Braunschweig and at Georgia Tech in Atlanta. She received her doctorate from EMBL in Heidelberg and, after postdoctoral research at the Salk Institute in San Diego and the MDC in Berlin, came to Helmholtz Zentrum München as group leader. She was also professor at the Gene Center of the LMU. In 2019, Prof. Uhlenhaut was appointed professor of 'Metabolic Programming' at the TUM.
Fields of Work and Expertise
Nuclear hormone receptors Transcription Chromatin Genomics Metabolism
Gene Regulation Inflammation Hormones Circadian Clocks Physiology
Professional Background
Director of the Institute for Diabetes and Endocrinology
W3 Professor at TUM School of Life Sciences, Chair for Metabolic Programming
W2 Professor LMU Gene Center
Emmy Noether group leader at HDC Helmholtz Munich
Honors and Awards
- 2023 EJE Award of the European Society of Endocrinology
- 2023 ERC GRACE
- 2022 Science Prize from the city of Freising
- 2019 Heinz-Maier-Leibnitz Prize of the DFG
- 2015 Friedmund Neumann Prize of the Schering Foundation
- 2014 ERC Starting Grant SILENCE
